For 2QFY2024, the group’s earnings excluding exceptional items (EI) saw a 39% y-o-y increase to RM437 million.
IHH Healthcare has reported patmi of RM623 million ($187.9 million) for 2QFY2024 ended June 30, up 107% y-o-y from RM301 million recorded in 2QFY2023. Ebitda rose 34% y-o-y to RM1.4 billion within the same period.
The group also reported patmi of RM1.39 billion for 1HFY2024, down 18% y-o-y from RM1.69 billion from 1HFY2023.
